Dr. Tony Coles

Home/Dr. Tony Coles
Dr. Tony Coles 2017-06-12T01:45:43+00:00
headshot-tony coles-sq-165.jpg
790 Memorial Drive Cambridge Massachusetts 02139 US
Founding Investor, Chairman & CEO
Yumanity Therapeutics
(617) 409-5300
Culture Shifting Award 2016
Award Event
Culture Shifting Awards - Silicon Valley 2016 (Menlo Park, CA)
Award Date
March 2016
Award Organizer/Grantor
Culture Shift Labs

Dr. Coles is a founding investor and the chairman and chief executive officer of Yumanity Therapeutics, a Cambridge, MA-based biotechnology company focused on transforming drug discovery for neurodegenerative diseases.

Dr. Coles also serves as chairman and chief executive officer of TRATE Enterprises, LLC, a privately held company.

Previously, Dr. Coles was chairman and chief executive officer of Onyx Pharmaceuticals, Inc., which was acquired by Amgen in late 2013. Prior to joining Onyx in 2008, he was president, chief executive officer and a member of the board of directors of NPS Pharmaceuticals, Inc. Before joining NPS Pharmaceuticals in 2005, Dr. Coles was senior vice president of commercial operations at Vertex Pharmaceuticals Inc., and earlier, held a number of executive positions at Bristol-Myers Squibb Company and positions of increasing responsibility at Merck & Co., Inc.